# Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB

> **NCT01805258** · PHASE3 · COMPLETED · sponsor: **All India Institute of Medical Sciences** · enrollment: 135 (actual)

## Conditions studied

- HIV/TB Co-infection

## Interventions

- **DRUG:** Nevirapine
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT01805258
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2012-12
- **Final completion:** 2013-02
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2013-03-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01805258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01805258, "Efficacy and Safety of Concomitant Use of Nevirapine and Rifampicin With HIV-TB". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01805258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*